Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHARMACOLOGY > CHAPTER 16: ANTIHYPERTENSIVES- Treatments > Flashcards

CHAPTER 16: ANTIHYPERTENSIVES- Treatments Flashcards

Beta Blockers, ACE Inhibitors, Calcium Channel Blockers, Vasodilators

1
Q

what types of drugs can be used to control blood pressure?

A

ACE inhibitors, angiotensin II receptor blockers, calcium channel blockers, vasodilators, diuretics, alpha/beta blockers, renin inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the first step before implementing drugs in the treatment of hypertensive patients?

A

lifestyle modifications!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

BETA BLOCKERS: main actions and side effects

A

we want to reduce CO, dec BP as a result
ACTION: REDUCE CO
- dec HR, force of contraction, and AV conduction

SIDE EFFECTS:
- bradycardia
- lethargy
- GI disturbances
- CHF
- dec BP
- depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

B-adrenoceptor blocking agents
- therapeutic actions

A
  • reduce BP by dec CO
  • dec sympathetic outflow from CNS
  • inhibit renin release–> dec angiotensin II and aldosterone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

B-adrenoceptor blocking agents: list drugs and the receptors they target

A

propanolol: non-selective, prototype
metoprolol and atenolol: common B1 blocker
nebivolol: B1 blocker, inc production of nitric oxide in arteries—> VASODILATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

B-adrenoceptor blocking agents: therapeutic uses/indications

A

hypertensive PTs w/heart disease

  • contraindication with reversible bronchospastic disease–> asthma, heart block, PVD, COPD

-if non-selective may go on B2 in lungs
-peripheral vascular disease: may worsen with the inc of peripheral resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

B-adrenoceptor blocking agents: adverse effects

A

COMMON
-hypotension, bradycardia, fatigue, insomnia, sexual dysfunction

METABOLIC
-disrupt lipid metabolism (B2 is sugar metab, B1 inc lipolysis when activated, dec when disrupted)

abrupt withdrawal: severe rebound hypertension, angina, MI, MUST TAPER DRUG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ACE Inhibitors
- ACE stands for what?
- used for what type of patients?

A
  • Angiotensin-converting enzymes
  • end in -pril

first line of treatment for hypertension in patients with OTHER conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ACE INHIBITORS: overview
-action, MOA, and effects

A

ACTION: dec peripheral vascular resistance
MOA: block enzyme ACE, cleaves angiotensin I to form vasoconstrictor angiotensin II

EFFECTS
- dizziness
-orthostatic hypotension
-GI distress
-nonproductive cough/ dry cough
- headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ACE Inhibitors: therapeutic effects

A

-dec BP by reducing peripheral vasc resistance WITHOUT reflex inc CO/HR/Contractility

-dec aldosterone secretion–>dec sodium and water retention
-reduce cardiac preload and afterload–> dec workload on heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PRELOAD and AFTERLOAD

A

Pre: BV in ventricles at end of diastole
After: resistance left ventricle must overcome to circulate blood

INC AFTER LOAD=INC CARDIAC WORKLOAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ACE Inhibitors: therapeutic uses/indications

A

-hypertension
-hypertensive PT w/diabetic nephropathy
-myocardial infarction & systolic dysfunction
-L ventricular hypertrophy, prevention of ventricular remodeling after MI
-HF, hypertensive PT w/chronic kidney disease, those w/inc risk of CAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is diabetic nephropathy?

A

kidney damage from diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is ventricular hypertrophy?

A

the thickening of ventricle walls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is ventricular remodeling and why might we want to prevent it?

A

remodeling/thickening the walls of the ventricles after an MI could be bad for patients who just experienced heart problems, we want to prevent this by giving less work to the ventricles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ACE Inhibitors: pharmacokinetics

A
  • oral drugs
  • only enalaprilat is IV (not a pro-drug)
17
Q

ACE inhibitors:
- captopril and lisinopril
-fosinopril

A
  • only drugs that don’t undergo hepatic conversion to active metabolites
  • good for PTs with hepatic impairment

fosinopril: not eliminated primarily by kidneys, no dose adjustment in patients w/ renal impairment

18
Q

pro-drug

A

is it the inactive form of the drug
- so enalapril is the inactive form and enalaprilat is the active form
-metabolism in the liver and drug w/specific enzymes make the drug active

19
Q

ACE Inhibitors: adverse effects

A

-MOST COMMON: dry cough
-angioedema
-hyperkalemia, monitor K+, use supplements and potassium sparing diuretics with caution
-serum creatinine monitored in renal-diseased PTs
- fetal malformations (teratogenic)

20
Q

Calcium Channel Blockers: overview
- actions, side effects

A

ACTIONS
-BLOCK calcium access to cells
-causes DEC contractility and conductivity, DEC demand for O2

EFFECTS
-DEC BP, bradycardia, AV block, headache, abdominal discomfort (constipation/nausea), peripheral edema

21
Q

Calcium Channel Blockers: when is it used
- avoid high doses why?

A
  • 1st treatment for African American PTs
  • hypertensive PTs w/diabetes or stable ischemic heart disease
    -AVOID high doses of short-acting Ca blockers, can cause excessive vasodilation and reflex cardiac stimulation (INC risk of MI)
22
Q

Calcium Channel Blockers: MOA and therapeutic effect

A

MOA: block inward movement of calcium, binding to L-type calcium channels in the heart and smooth muscle of coronary and peripheral arteries

effect: relax vasc smooth muscle, dilate arteriole
DO NOT DILATE VEINS

23
Q

Calcium Channel Blockers: therapeutic uses/indications

A

-manage hypertension
-treat hypertensive PTs with asthma, diabetes, PVD
-angina
-atrial fibrillation

24
Q

which two calcium channel blockers are used for atrial fibrillation?

A

diltiazem and verapamil
- they have a positive profile–> least adverse effects

25
Q

Calcium Channel Blockers: VERAPAMIL

A

-cardiac and vasc smooth muscle effects
-use for supraventricular tachyarrhythmias
-prevent migraine and cluster headaches
CROSSES THE BBB

26
Q

Calcium Channel Blockers: DILTIAZEM

A

-cardiac and vasc smooth muscle effects
-LESS neg inotropic effect on heart compared to verapamil
-favorable side effect profile

27
Q

Calcium Channel Blockers: NIFEDIPINE

A

-prototype
-amlodipine, felodipine, isradipine, nicardipine, nisoldipine: great affinity for vasc than heart calcium channels—> helpful to treat hypertension
-little interaction w other CV drugs like digoxin or warfarin

28
Q

Calcium Channel Blockers: compare dilation of coronary vessels, AV conduction, and frequency of adverse effects

A

Dilation of coronary vessels: nifedipine and diltiazem best

AV conduction: verapamil most, nifedipine least

Freq of Adv Effects: nifedipine most, diltiazem least

29
Q

Calcium Channel Blockers: adverse effects

A

verapamil: dose-dependent atrioventricular block and constipation

verapamil and diltiazem: avoid in PT with HF or AV block due to NEG INOTROPIC and DROMOTOPIC effects

nifedipine/-dipines: dizziness, headaches, fatigue due to dec BP, peripheral edema, gingival hyperplasia (swollen gums)

30
Q

what to consider for calcium channel blockers?
- ER

A

if EXTENDED RELEASE, cannot be crushed or cut
-too much of drug will be released at one time and induce toxic levels of the drug

31
Q

VASODILATORS: which drugs and uses?

A

hydralazine, minoxidil, nitroprusside

-used when previous drugs are not effective
-reserved for SEVERE hypertension/hypertensive emergencies

-act on potassium channels of vasc smooth muscles

32
Q

vasodilators: methods of administration for each drug

A

hydralazine: PO, IV, IM
minoxidil- PO
nitroprusside- IV

33
Q

VASODILATORS: therapeutic effects

A

direct-acting on smooth muscles
- produce vasc muscle relaxation and vasoDILATION
-DEC peripheral resistance, DEC BP

34
Q

hypertensive urgency vs emergency

A

URGENCY: severe elevated BP, no current evidence of end-organ damage ( may occur if left untreated)
-DEC BP soon

EMERGENCY: severe elevated BP w/evidence of end-organ damage
-DEC BP IMMEDIATELY

35
Q

VASODILATORS: adverse effects

A

CV: reflex stimulate heart–> INC CO, HR, O2 consumption, angina, MI, or cardiac failure
-use B blocker to balance reflex tachycardia

GU: inc plasma renin conc–> sodium and water retention
-use diuretics to dec sodium retention

36
Q

VASODILATORS: hydralazine, minoxidil, nitroprusside—->specific adverse effects

A

hydralazine: headache, tachycardia, nausea, sweating, arrhythmia, precipitation of angina
-lupus like syndrome w HIGH doses

minoxidil: hypertrichosis (excessive hair growth)

nitroprusside: metabolized into cyanide–>cyanide toxicity, dyspnea, ataxia, loss of conscious, distant heart sounds, dilated pupil

37
Q

what is dyspnea?

A

difficult/labored breathing

38
Q

what is ataxia?

A

impaired coordination/loss of balance due to damage to brain, nerves, or muscles

PHARMACOLOGY (29 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions